266 related articles for article (PubMed ID: 9020786)
1. Interaction of estramustine with tubulin isotypes.
Laing N; Dahllöf B; Hartley-Asp B; Ranganathan S; Tew KD
Biochemistry; 1997 Jan; 36(4):871-8. PubMed ID: 9020786
[TBL] [Abstract][Full Text] [Related]
2. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
Ranganathan S; McCauley RA; Dexter DW; Hudes GR
Br J Cancer; 2001 Sep; 85(5):735-40. PubMed ID: 11531260
[TBL] [Abstract][Full Text] [Related]
3. Estramustine depolymerizes microtubules by binding to tubulin.
Dahllöf B; Billström A; Cabral F; Hartley-Asp B
Cancer Res; 1993 Oct; 53(19):4573-81. PubMed ID: 8402630
[TBL] [Abstract][Full Text] [Related]
4. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance.
Ranganathan S; Dexter DW; Benetatos CA; Chapman AE; Tew KD; Hudes GR
Cancer Res; 1996 Jun; 56(11):2584-9. PubMed ID: 8653701
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action.
Panda D; Miller HP; Islam K; Wilson L
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10560-4. PubMed ID: 9380674
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of bovine brain microtubule assembly in vitro by stypoldione.
O'Brien ET; Jacobs RS; Wilson L
Mol Pharmacol; 1983 Nov; 24(3):493-9. PubMed ID: 6633509
[TBL] [Abstract][Full Text] [Related]
7. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
8. Two photoaffinity analogues of the tripeptide, hemiasterlin, exclusively label alpha-tubulin.
Nunes M; Kaplan J; Wooters J; Hari M; Minnick AA; May MK; Shi C; Musto S; Beyer C; Krishnamurthy G; Qiu Y; Loganzo F; Ayral-Kaloustian S; Zask A; Greenberger LM
Biochemistry; 2005 May; 44(18):6844-57. PubMed ID: 15865430
[TBL] [Abstract][Full Text] [Related]
9. Estramustine-based chemotherapy.
Hudes G
Semin Urol Oncol; 1997 Feb; 15(1):13-9. PubMed ID: 9050135
[TBL] [Abstract][Full Text] [Related]
10. Association of estramustine resistance in human prostatic carcinoma cells with modified patterns of tubulin expression.
Sangrajrang S; Denoulet P; Laing NM; Tatoud R; Millot G; Calvo F; Tew KD; Fellous A
Biochem Pharmacol; 1998 Feb; 55(3):325-31. PubMed ID: 9484799
[TBL] [Abstract][Full Text] [Related]
11. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
12. Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents.
Legault J; Gaulin JF; Mounetou E; Bolduc S; Lacroix J; Poyet P; Gaudreault RC
Cancer Res; 2000 Feb; 60(4):985-92. PubMed ID: 10706114
[TBL] [Abstract][Full Text] [Related]
13. Stoichiometry of estramustine phosphate binding to MAP2 measured by the disassembly of chick brain MAP2:tubulin microtubules.
Burns RG
Cell Motil Cytoskeleton; 1990; 17(3):167-73. PubMed ID: 2125244
[TBL] [Abstract][Full Text] [Related]
14. Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.
Speicher LA; Laing N; Barone LR; Robbins JD; Seamon KB; Tew KD
Mol Pharmacol; 1994 Nov; 46(5):866-72. PubMed ID: 7969073
[TBL] [Abstract][Full Text] [Related]
15. Effect of estramustine phosphate on the assembly of isolated bovine brain microtubules and fast axonal transport in the frog sciatic nerve.
Kanje M; Deinum J; Wallin M; Ekström P; Edström A; Hartley-Asp B
Cancer Res; 1985 May; 45(5):2234-9. PubMed ID: 2580617
[TBL] [Abstract][Full Text] [Related]
16. Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents.
Ranganathan S; Dexter DW; Benetatos CA; Hudes GR
Biochim Biophys Acta; 1998 Jan; 1395(2):237-45. PubMed ID: 9473684
[TBL] [Abstract][Full Text] [Related]
17. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
Lobert S; Vulevic B; Correia JJ
Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
[TBL] [Abstract][Full Text] [Related]
18. Derivatives of 5,6-diphenylpyridazin-3-one: synthetic antimitotic agents which interact with plant and mammalian tubulin at a new drug-binding site.
Batra JK; Powers LJ; Hess FD; Hamel E
Cancer Res; 1986 Apr; 46(4 Pt 2):1889-93. PubMed ID: 3948171
[TBL] [Abstract][Full Text] [Related]
19. Antiinvasive activity of estramustine on malignant MO4 mouse cells and on DU-145 human prostate carcinoma cells in vitro.
Mareel MM; Storme GA; Dragonetti CH; De Bruyne GK; Hartley-Asp B; Segers JL; Rabaey ML
Cancer Res; 1988 Apr; 48(7):1842-9. PubMed ID: 3349462
[TBL] [Abstract][Full Text] [Related]
20. Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest.
Eklöv S; Mahdy E; Wester K; Björk P; Malmström PU; Busch C; Nilsson S
Anticancer Res; 1996; 16(4A):1819-22. PubMed ID: 8712706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
